This study examines the plan characteristics associated with generic risperidone use and spending and adherence outcomes associated with use among Medicare Advantage Part D beneficiaries.
Andrew A. Nierenberg, MD
Advertisement
Articles by Andrew A. Nierenberg, MD
Advertisement
Latest Updated Articles
- The Introduction of Generic Risperidone in Medicare Part D
Published: January 20th 2016 | Updated:
- Current Perspectives on the Diagnosis and Treatment of Major Depressive Disorder
Published: September 1st 2001 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Value-Based Care Interventions and Management of CKD Progression
5
